Adia Nutrition Sells Biolete Coffee to Cement Factory LLC, Retains 18% Stake to Focus on Regenerative Medicine Expansion

Reuters
Oct 07, 2025
<a href="https://laohu8.com/S/ADIA">Adia Nutrition</a> Sells Biolete Coffee to Cement Factory LLC, Retains 18% Stake to Focus on Regenerative Medicine Expansion

Adia Nutrition Inc. has sold its Biolete coffee subsidiary to Cement Factory LLC, a consumer products company led by Jeff Sciullo and AJ Sims. As part of the transaction, Adia retains an 18% ownership stake in Cement Factory, maintaining a strategic interest in Biolete's future. The sale allows Adia to sharpen its focus on expanding its regenerative medicine business, including scaling Adia Med clinics, growing its specialized sales force, and advancing treatments for chronic conditions. Proceeds from the sale will support further development of Adia's medical initiatives. Cement Factory plans to build on Biolete's health-focused beverage offerings by enhancing its e-commerce presence and investing in research and development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 269272) on October 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10